top of page

Credentials

Degrees:
PhD, MSc, Molecular Biology - Laval University
BSc, Biological Sciences - Universite Paris V

Development:

  • Emotional Intelligence

  • Situational Leadership

  • Change Management

  • Finance

  • OKRs, KPIs

  • Principles of Ownership, Control, Access, and Possession (OCAP®)

​

Languages:

  • Fluent in English, French, and Portuguese

Expertise

Executive Operations:

  • Profit & Loss Accountability

  • Audit Oversight

  • Financial Operations

  • Human Resources, Belonging and Performance Culture Stewardship

  • Governance, Risk & Compliance

  • Data Stewardship

  • Program Strategy & Implementation

  • Legal & Contract Oversight

  • Go-to-Market Strategy Support

  • Strategic Communication & Marketing Enablement​

​

Research & Development (R&D):

  • Program Design & Delivery

  • Partnership Development

  • Clinical Trial Oversight (Phases I–III)

  • Good Clinical Practices (GCP) and Pharmacovigilance

  • Prototype Development, Efficacy and Safety Product Validation at Accredited Testing Laboratories (GMP/GLP-Compliant, BSL-2/3) under ASTM, ASHRAE, ISO, UL, and Nemko Standards

  • Scientific & Technical Due Diligence

  • Technology Sourcing & Evaluation

  • Health Product Software-as-a-Service (SaaS) & Dashboard Development

  • Peer-Reviewed Publications

  • Logic Models, Summative/Formative Program Evaluations

 

Market Experience:​

  • Growth Stages: Pre-Seed, Series A–C, Post-IPO

  • Primary Markets: Canada, United States

  • Secondary Markets: United Kingdom, Germany, Australia​

​

Investment Oversight:​

  • $5-15 M Portfolios

  • Scientific Due-Diligence, Mergers & Acquisition Support

  • Strategic and Targeted Investments â€‹in Research, Technology, and Capacity Building

​

Domains and Partnerships:

  • Local, Provincial, Territorial, and Federal Government Agencies 

  • Indigenous Governments and Organizations

  • Medium to Large Universities, Schools

  • Startups and Scaleups

  • Non-Profit, Charitable, and Community-Based, and Sports Promotion Organizations

  • ​Molecular Biology Across Diverse Fields, Including Genetics, Neuroscience, Microbiology, Public Health, and Emerging Areas (Photonics) at the Intersection With Physics and Engineering.

​​​​

Regulatory:

  • Health Canada's Therapeutic Products Directorate (TPD), Natural and Non-prescription Health Products Directorate (NNHPD), Controlled Substances and CNS Branch, Veterinary Drugs Directorate (VDD), Pest Management Regulatory Agency and Associated Guidance Documents/Acts

  • U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) and Investigational Device Exemption (IDE) Regulations

  • Environmental Protection Agency’s (EPA) Office of Enforcement and Compliance Assurance (OECA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)

  • Canada Revenue Agency's Charities Directorate​

  • Treasury Board Budget Submissions

Roles

Chief Operating Officer - One Yukon Coalition

2023 - Present (Calgary)

  • ​Leading public health innovation in Northern Canada with full P&L responsibility.

  • Built a high-retention team, secured charitable status, joined the European SCORE network.

  • Implemented monitoring systems for respiratory viruses (SARS-CoV-2, influenza, RSV) and toxic substances, deployed rapid point-of-care testing (POCT), and collaborated with Canada’s highest-security biohazard facility (NML).

​

Director, Clinical Science - R-Zero

2021 - 2023 (Salt Lake City, USA)

  • Led R-Zero’s scientific programming with Mayo Clinic, Harvard, and Columbia University partners, integrating light and sensor technologies to advance infection prevention in public settings.

  • Directed new product validation, launched the Salt Lake City R&D lab, and supported Series C funding and major enterprise sales.

​

Director, Clinical Research - CleanSlate

2020 - 2021 (Toronto)

  • ​Positioned CleanSlate’s scientific division as a market leader in non-chemical disinfection efficacy against SARS-CoV-2.

  • Launched the company’s microbiology laboratory in Toronto and led a team of biologists and engineers through Health Canada registration, securing approval under the updated PCPA framework.

​

Director, Clinical Science - Aurora

2019 - 2020 (Edmonton(

  • ​Directed global clinical studies on novel treatments for epilepsy and pain, including a high-visibility partnership with the Ultimate Fighting Championship (UFC).

​

Team Lead, Project and Initiatives - Canadian Institutes of Health Research Institute of Neurosciences, Mental Health, and Addiction

2017 - 2018 (Calgary)

  • ​Allocated targeted Treasury Board investments to support public safety personnel, contributing to strategic planning, advisory board formation, program evaluation, and transparent public reporting.

​

Manager - Industry and Technology Initiatives - Alberta Innovates

2015 - 2017 (Edmonton)

  • ​Led province-wide research and capacity-building investments, overseeing peer review, fund allocation, and reporting.

  • Guided the team through an organizational merger while ensuring strategic alignment and program continuity.

​

Postdoctoral Fellow - University of Toronto, and University of Calgary

2011 - 2015 (Calgary)

  • Contributed to international research identifying a genetic link between cataracts and Alzheimer’s disease, advancing understanding of neurodegenerative conditions â€‹â€‹â€‹â€‹â€‹â€‹

​

Current Committees:

  • Community Member, Health Canada Science Advisory Committee on Pest Control Products

  • Ad hoc Member, Canadian Public Health Laboratory Network (CPHLN) - Data Governance & Reporting, and Surveillance Strategy & Pathogen Prioritization Task Forces

  • Board Member, Mindelio/Heros Biotech™

bottom of page